Morgan Stanley lowered the firm’s price target on Comerica (CMA) to $71 from $76 and keeps an Equal Weight rating on the shares. Operating EPS of $1.20 marginally beat the firm’s and consensus estimates, but 2025 expense guidance for growth of 3% missed the Street estimate of 1%, driving stock underperformance after earnings, the analyst tells investors. Net interest income guidance was in-line, but fee guidance was also slightly weaker than expected, the analyst added.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CMA:
